| Ytd | -7.40% | |
| 1y | 24.07% |
| Open | 5.88 | Prev Close | 5.91 | Low | 5.59 | High | 5.89 | Mkt Cap | 558.19M |
| Vol | 212.60K | Avg Vol | 1.62M | EPS | -0.13 | P/E | -45.46 | Forward P/E | 71.53 |
| Beta | 1.64 | Short Ratio | 4.83 | Inst. Own | 103.89% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 4.83 | 200-d Avg | 5.70 | 1yr Est | 19.41 |
MYGN News
Myriad Genetics Launches FirstGene® Multiple Prenatal Screen: The only lab test to run four prenatal
Genomics is reshaping healthcare, and these three stocks - MYGN, SANA and WVE - stand out as rapid a
Myriad Genetics, Inc. MYGN is well-placed for growth in the coming quarters due to its steady rollou
New published data shows Prolaris Biopsy Test adds significant prognostic information beyond convent
Myriad (MYGN) was a big mover last session on higher-than-average trading volume. The latest trend i
Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicin
Publication of MONITOR-Breast study marks latest milestone for clinical validity of Precise MRD Publ
MYGN is gearing up with oncology testing and steady product launches, backed by sound solvency, thou
Myriad (MYGN) reported earnings 30 days ago. What's next for the stock?
Genomics and synthetic biology are reshaping healthcare, with growing demand for precision medicine
SALT LAKE CITY, June 02, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in
MYGN plans to launch its Prolaris + AI Test this month, combining biomarker data and AI pathology to
Myriad Genetics trades near 0.4x sales as investors weigh cheap valuation against 2026 launch execut
Myriad Genetics ramps up oncology launches in 2026 as Cancer Care Continuum growth and GeneSight rei
SALT LAKE CITY, May 27, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in
SALT LAKE CITY, May 26, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in
Myriad (MYGN) is technically in oversold territory now, so the heavy selling pressure might have exh
SALT LAKE CITY, May 15, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in
SALT LAKE CITY, May 07, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in m
Myriad Genetics, Inc. (MYGN) Q1 2026 Earnings Call Transcript
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
During Monday's trading, 1214 companies set new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
On Monday, 721 companies achieved new lows for the year.
Tuesday's session saw 729 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Tuesday
Stocks That Hit 52-Week Lows On Friday
Stocks That Hit 52-Week Lows On Thursday